IL134111A0 - Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation - Google Patents

Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation

Info

Publication number
IL134111A0
IL134111A0 IL13411198A IL13411198A IL134111A0 IL 134111 A0 IL134111 A0 IL 134111A0 IL 13411198 A IL13411198 A IL 13411198A IL 13411198 A IL13411198 A IL 13411198A IL 134111 A0 IL134111 A0 IL 134111A0
Authority
IL
Israel
Prior art keywords
compounds
preparation
compositions containing
anovel
triazolo
Prior art date
Application number
IL13411198A
Other languages
English (en)
Original Assignee
Astra Pharmaceuticals Ltd Astr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceuticals Ltd Astr filed Critical Astra Pharmaceuticals Ltd Astr
Publication of IL134111A0 publication Critical patent/IL134111A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
IL13411198A 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation IL134111A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (en) 1997-07-22 1998-07-15 Novel compounds

Publications (1)

Publication Number Publication Date
IL134111A0 true IL134111A0 (en) 2001-04-30

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13411198A IL134111A0 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation

Country Status (21)

Country Link
US (1) US6166022A (de)
EP (1) EP0998475B1 (de)
JP (1) JP2001510843A (de)
KR (1) KR20010022084A (de)
CN (1) CN1270591A (de)
AT (1) ATE216390T1 (de)
AU (1) AU8370798A (de)
BR (1) BR9811028A (de)
CA (1) CA2296426A1 (de)
DE (1) DE69804966T2 (de)
EE (1) EE200000048A (de)
HU (1) HUP0003826A3 (de)
ID (1) ID25856A (de)
IL (1) IL134111A0 (de)
IS (1) IS5352A (de)
NO (1) NO20000313L (de)
PL (1) PL338181A1 (de)
SE (1) SE9702774D0 (de)
SK (1) SK188299A3 (de)
TR (1) TR200000152T2 (de)
WO (1) WO1999005144A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
JP2002503663A (ja) * 1998-02-17 2002-02-05 アストラゼネカ ユーケイ リミテッド 新規のトリアゾロ（４，５−ｄ）ピリミジン化合物
US6593489B1 (en) 1999-09-09 2003-07-15 Chirotechtechnology Limited Substituted cyclopentenes, their preparation and their use for chiral scaffolds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7435724B2 (en) * 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
AU2004278030C1 (en) 2003-10-03 2010-12-02 Portola Pharmaceuticals, Inc. 2,4-Dioxo-3-quinazolinylaryl sulfonylureas
MXPA06003625A (es) 2003-10-03 2006-08-11 Portola Pharm Inc Isoquinolinonas sustituidas.
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
EP1685135B1 (de) 2003-10-21 2010-05-26 Inspire Pharmaceuticals, Inc. Tetrahydrofuro[3,4-d]dioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
AU2005292314B2 (en) 2004-09-29 2011-11-03 Portola Pharmaceuticals, Inc. Substituted 2H-1,3-benzoxazin-4(3H)-ones
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
WO2007020935A1 (ja) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
CA2627719C (en) 2005-11-03 2016-07-12 Portola Pharmaceuticals, Inc. [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
WO2008054795A2 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
IN2012CN10271A (de) * 2010-05-27 2015-04-10 Reddy’S Lab Ltd Dr
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
JPH08506343A (ja) * 1993-02-03 1996-07-09 ジェンシア・インコーポレイテッド リキソフラノシル誘導体を含むアデノシンキナーゼ阻害物質
BR9609467A (pt) * 1995-07-11 1999-03-02 Astra Pharma Prod Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária

Also Published As

Publication number Publication date
DE69804966T2 (de) 2002-11-07
ID25856A (id) 2000-11-09
CA2296426A1 (en) 1999-02-04
HUP0003826A2 (hu) 2001-04-28
SE9702774D0 (sv) 1997-07-22
US6166022A (en) 2000-12-26
IS5352A (is) 2000-01-19
NO20000313L (no) 2000-03-22
EP0998475A1 (de) 2000-05-10
SK188299A3 (en) 2000-08-14
KR20010022084A (ko) 2001-03-15
BR9811028A (pt) 2000-08-01
CN1270591A (zh) 2000-10-18
JP2001510843A (ja) 2001-08-07
PL338181A1 (en) 2000-10-09
HUP0003826A3 (en) 2001-11-28
WO1999005144A1 (en) 1999-02-04
DE69804966D1 (de) 2002-05-23
EE200000048A (et) 2000-10-16
EP0998475B1 (de) 2002-04-17
TR200000152T2 (tr) 2000-07-21
AU8370798A (en) 1999-02-16
NO20000313D0 (no) 2000-01-21
ATE216390T1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
IL134111A0 (en) Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
IL134112A0 (en) Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
IL132153A0 (en) Novel compounds
CY2365B1 (en) Pyrrolopyrimidines and processes for the preparation thereof.
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
MY121867A (en) Novel triazolo(4,5-d)pyrimidine compounds.
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
HUT70505A (en) Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them
IL136499A0 (en) Pyrrolo-, thieno-, furano- and pyrazolo-[3,4,d] pypyrrolo-, thieno-, furano- and pyrazolo-[3,4,d] pyridazinone compounds, process for their preparatioridaziones compounds, process for their preparation, pharmaceutical compositions containing them, a n, pharmaceutical compositions containing them, a process for prepating the pharmaceutical compositiprocess for preparing the pharmaceutical compositions, and use thereof ons, and use thereof
CA2316921A1 (en) Aryl fused azapolycyclic compounds
IL130538A0 (en) Pyrrolo ¬3,4-d¾pyrimidinone derivatives and their use as medicaments
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
SE9702563D0 (sv) Compounds
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
AU2002214467A1 (en) Novel compounds
CA2235967A1 (en) Diarylethylene metallocene derivatives, their processes of preparation and pharmaceutical compositions containing said derivatives